Stereoselective crystallization of 3-(2,6-dimethylphenoxy)propane-1,2-diol: preparation of the single-enantiomer drug mexiletine
Authors:
- Zemfira A. BredikhinaZBZemfira A. Bredikhina
- Alexey V. KurenkovAKAlexey V. Kurenkov
- Dmitry B. KrivolapovDKDmitry B. Krivolapov
- Alexander A. BredikhinABAlexander A. Bredikhin
- 1 May 2015
- journal article
- Published by Elsevier in Tetrahedron: Asymmetry
- Vol. 26 (10-11) , 577-583
Abstract
No abstract availableFunding Information
- Russian Fund of Basic Research (15-43-02238)
This publication has 39 references indexed in Scilit:
- Searching for new antiarrhythmic agents: Evaluation of meta-hydroxymexiletine enantiomersEuropean Journal of Medicinal Chemistry, 2013
- Immobilization of ω-transaminases by encapsulation in a sol–gel/celite matrixJournal of Molecular Catalysis B: Enzymatic, 2010
- Deracemization of Mexiletine Biocatalyzed by ω-TransaminasesOrganic Letters, 2009
- From Racemates to Single Enantiomers – Chiral Synthetic Drugs over the last 20 Years2006
- Optically Active Mexiletine Analogues as Stereoselective Blockers of Voltage-Gated Na+ChannelsJournal of Medicinal Chemistry, 2003
- Impact of Stereoselectivity on the Pharmacokinetics and Pharmacodynamics of Antiarrhythmic DrugsClinical Pharmacokinetics, 2002
- Preparation of highly enantiopure stereoisomers of 1-(2,6-dimethylphenoxy)-2-aminopropane (mexiletine)Tetrahedron: Asymmetry, 1999
- Stereospecific synthesis and absolute configuration of mexiletineChirality, 1994
- Resolution and Electrophysiological Effects of Mexiletine EnantiomersJournal of Pharmacy and Pharmacology, 1991
- Analytical Profile of Mexiletine HydrochlorideAnalytical Profiles of Drug Substances, 1991